Skip to content

(Cost)effectiveness of a cognitive group prevention module for recurrent depression.

(Cost)effectiveness of a cognitive group prevention module for recurrent depression.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27974
Enrollment
187
Registered
2005-10-12
Start date
1999-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment as usual versus treamt as usual + cognitive therapy.

Interventions

Cognitive therapy (CT). The CT in the experimental condition involved eight weekly two-hour sessions. As in other prevention studies (Ma &Teasdale, 2004
Teasdale et al., 2000) a group format was chosen, for cost-effectiveness reasons but also because we were dealing with a patient group without current psychopathology. More specifically, we used a c
all were fully trained cognitive behavior therapists (minimum of 5 years of training). Before conducting the experimental groups, each therapist received 16 hours of additional specific training. A tr
Beck, Rush, Shaw, & Emery, 1979), the present module was not primarily directed toward modifying negative thoughts. Instead, it started with the identification of negative thoughts (Session 1) and dys

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: To be eligible, patients had to meet the following criteria: 1. Experienced at least two Major Depressive Episodes (MDEs) in the previous five years, as defined according to the Diagnostic and Statistical Manual of mental Disorders (DSM-IV: American Psychiatric Association, 1994) and assessed with the Structured Clinical Interview for DSM-IV (SCID; First, Gibbon, Spitzer, & Williams, 1996) administered by trained interviewers; 2. Were currently in remission according to DSM-IV criteria, for longer than ten weeks and no longer than two years (i.e. a high-risk group of relapse/recurrence); 3. Obtained a current score of <10 on the Hamilton Rating Scale for Depression (Hamilton, 1960).

Exclusion criteria

Exclusion criteria: Exclusion criteria were current mania or hypomania or a history of bipolar illness, any psychotic disorder (current and previous), organic brain damage, alcohol or drug misuse, predominant anxiety disorder, recent ECT, recent cognitive treatment or receiving CT at the start of the study, or current psychotherapy with a frequency of more than two times a month.

Design outcomes

Primary

MeasureTime frame
Relapse/recurrence To assess relapse/recurrence, we used the Structured Clinical Interview for DSM-IV (SCID-I; First, Gibbon, Spitzer, & Williams, 1996) was used. At baseline and at three follow-up assessments (3, 12, and 24 months), current and past depressive episodes were checked.

Secondary

MeasureTime frame
The number of relapse/recurrence and severity relapse/recurrence.

Contacts

Public ContactClaudi Bockting

Academic Medical Center (AMC) / De Meren Tafelbergweg 25 P2-221

c.l.bockting@amc.uva.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)